Impact of Timely Alzheimer Diagnosis on Treatment Selection and Disease Progression

Panelists discuss how early diagnosis directly affects therapeutic eligibility and long-term outcomes in Alzheimer disease. With new disease-modifying therapies emerging, recognizing cognitive decline sooner allows clinicians to intervene before significant neurodegeneration occurs.

Panelists discuss how timely identification supports more individualized treatment strategies, enabling advanced practice providers (APPs) and physicians to balance pharmacologic and supportive interventions based on disease stage and patient preference. They emphasize that early diagnosis provides families time to plan, adjust expectations, and participate actively in care decisions.

Panelists discuss how delaying diagnosis often leads to missed opportunities for disease-modifying therapy and increased caregiver burden. By streamlining assessment protocols and fostering interdisciplinary cooperation, APPs help ensure patients receive therapy at the most effective window of opportunity.